Falciparum malaria treated with a chloroquine suspension administered rectally in Trinidad
West Indian med. j
; 43(1): 26, Mar. 1994.
Article
in English
| MedCarib
| ID: med-8352
Responsible library:
JM3.1
Localization: JM3.1; R18.W4
ABSTRACT
A new mode of administering malaria chemotherapy to patients unable to tolerate oral medication is described. A patient with Plasmodium falciparum malaria, severe hyponatraemia and hypokalaemia who regurgitated oral treatment of chloroquine phosphate and pyrimethamine and sulfadoxine (Fansidar) is presented. But neither chloroquine nor quinine intravenous formulations were available locally. As the patient was deteriorating, a suspension of chloroquine phosphate was prepared and administered rectally, resulting in a decline in the level of parasitaemia from ++++ to ++ within 48 hours. The patient improved, and further clinical management was uncomplicated (AU)
Search on Google
Collection:
International databases
Health context:
SDG3 - Health and Well-Being
/
Neglected Diseases
Health problem:
Target 3.3: End transmission of communicable diseases
/
Malaria
/
Neglected Diseases
Database:
MedCarib
Main subject:
Malaria
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
West Indian med. j
Year:
1994
Document type:
Article